openPR Logo
Press release

Choroideremia Treatment Market Present Scenario and Future Forecast to 2026: Biogen, 4D Molecular Therapeutics, Copernicus Therapeutics, Inc

03-26-2020 12:35 PM CET | Health & Medicine

Press release from: Data Bridge Market Research

Choroideremia Treatment Market

Choroideremia Treatment Market

Choroideremia Treatment Market is inclusive of an in-depth evaluation of this industry, and a commendable brief of its segmentation. The report, in a nutshell, incorporates a basic overview of the market with respect to its current status and the market size, with regards to its volume and revenue. Also, the study is inclusive of a summary of important data considering the regional scope of the industry as well as the firms that seem to have strongly established their position across the Choroideremia Treatment Market.

Global Choroideremia Treatment Market is expected to grow at a steady CAGR in the forecast period of 2019-2026. Increase in strategic alliances between the pharmaceuticals companies and high demand of disease specific novel therapies are the key factors that fueling the market growth.

Download exclusive PDF sample report @ https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-choroideremia-treatment-market

Some of the major competitors currently working in the global choroideremia treatment market are Biogen, 4D Molecular Therapeutics, Copernicus Therapeutics, Inc, Wize Pharma Inc, Spark Therapeutics, Inc, PIXIUM VISION, Retina Implant AG, F. Hoffmann-La Roche Ltd and others.

Market Definition:

Choroideremia is also known as choroidal sclerosis is a rare, degenerative, X-linked inherited retinal disorder characterized by progressive degeneration of the choroid, retinal pigment epithelium (RPE) and retina due to Mutations in the CHM gene. This CHM gene required to produce Rab escort protein-1 (REP-1). The condition gets its name from the distinctive sweet odor of affected infant's urine and is also c, a protein that takes part in targeting vesicles (small sacs of substances) into, out of, and within cells.

According to the statistics published by U.S. Department of Health & Human Services, an estimated population of choroideremia is about 1 in 50,000-100,000 people. Presence of refined healthcare infrastructure and emerging new market are the key factors for growth of this market.

Market Drivers

Ongoing clinical trial conducted by many pharmaceuticals industries is propelling the growth of this market

Increase in special designation from the regulatory authorities is boosting the market growth

High demand of disease specific novel treatment can also act as a market driver

The competitive scenario of market and strategic collaborations may boost the market position

Market Restraints

Limited operating revenue opportunities for research and development of targeted therapies
by many pharmaceuticals is acting as a challenging factor for the growth of this market

Low healthcare budget in some developing countries is hampering the market growth

Treatment by Surgery may alter the appearance and function of the eye can threats the patients is also hindered the market growth

Segmentation: Global Choroideremia Treatment Market

By Treatment

Gene Therapy
Surgery

By Route of Administration

Oral
Injectable

By End Users

Hospitals
Homecare
Specialty Clinics
Ophthalmic Clinics
Others

By Distribution Channel

Hospital Pharmacies
Retail Pharmacies

By Geography

North America
South America
Europe
Asia-Pacific
Middle East & Africa

Table Of Contents: Global Choroideremia Treatment Market

Part 01: Executive Summary
Part 02: Scope Of The Report
Part 03: Research Methodology
Part 04: Market Landscape
Part 05: Pipeline Analysis
Part 06: Market Sizing
Part 07: Five Forces Analysis
Part 08: Market Segmentation
Part 09: Customer Landscape
Part 10: Regional Landscape
Part 11: Decision Framework
Part 12: Drivers And Challenges
Part 13: Market Trends
Part 14: Vendor Landscape
Part 15: Vendor Analysis
Part 16: Appendix

Download Detailed TOC @ https://www.databridgemarketresearch.com/toc/?dbmr=global-choroideremia-treatment-market

Key Developments in the Market:

In June 2019, Biogen has acquired Nightstar Therapeutics for USD 800 million approximately. With this acquisition, Biogen will take the responsibility of two mid- to late-stage clinical assets, as well as preclinical programs in ophthalmology including NSR-REP1 for the treatment of choroideremia.

In November 2018, 4D Molecular Therapeutics received an Orphan Drug designation from the FDA for to 4D-110, an intravitreal injection AAV gene therapy agent for the treatment of choroideremia. With this designation company enables to obtain marketing exclusivity upon approval of the product in the designated indication.

Competitive Analysis:

Global choroideremia treatment market is highly fragmented and the major players have used various strategies such as new product launches, expansions, agreements, joint ventures, partnerships, acquisitions, and others to increase their footprints in this market. The report includes market shares global choroideremia treatment market for Global, Europe, North America, Asia-Pacific, South America and Middle East & Africa.

Reasons to Purchase this Report

Current and future of global choroideremia treatment market outlook in the developed and emerging markets

The segment that is expected to dominate the market as well as the segment which holds highest CAGR in the forecast period

Regions/Countries that are expected to witness the fastest growth rates during the forecast period

The latest developments, market shares, and strategies that are employed by the major market players

Order a Copy of Global Choroideremia Treatment Market Report @ https://www.databridgemarketresearch.com/inquire-before-buying/?dbmr=global-choroideremia-treatment-market

Contact:

Data Bridge Market Research

US: +1 888 387 2818

UK: +44 208 089 1725

Hong Kong: +852 8192 7475

Email: Corporatesales@databridgemarketresearch.com

About Data Bridge Market Research

An absolute way to forecast what future holds is to comprehend the trend today!

Data Bridge set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process. Data Bridge is an aftermath of sheer wisdom and experience which was formulated and framed in the year 2015 in Pune.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Choroideremia Treatment Market Present Scenario and Future Forecast to 2026: Biogen, 4D Molecular Therapeutics, Copernicus Therapeutics, Inc here

News-ID: 1985903 • Views: 85

More Releases from Data Bridge Market Research

Robotic Process Automation (RPA) Market Competitive Outlook: Automation Anywhere …
A new business intelligence report released by Data Bridge Market research with titled "Global Robotic process automation Market" (covering USA, Europe, China, Japan, India, South East Asia and etc) that targets and provides comprehensive market analysis with future prospects to 2026. This rise in the market can be attributed due to rising popularity and attractiveness of enterprise resource planning which is driving the needs of the business to
Digital Assurance Market Competitive Outlook: Atos, Accenture, Capgemini, Cignit …
Data Bridge Market researchhas recently released expansive research on Global Digital Assurance Market with 100+ market data Tables, Pie Chart, Graphs & Figures spread through Pages and easy to understand detailed analysis. The report endows with wide-ranging statistical analysis of the market's continuous developments, capacity, production, production value, cost/profit, supply/demand and import/export. This market report provides best solutions for strategy development and implementation depending on client's needs to extract tangible
Rear E Axle Market Future Outlook | ZF Friedrichshafen AG, Schaeffler AG,Contine …
Front rear E axle market will register the growth rate of 23.50% for the forecast period of 2020 to 2027. Rising usage of E-axle in ICE vehicles is expected to create new opportunity for the market. Growing sales of electric and hybrid vehicles is expected to enhance the market growth. Some of the other factors such as increasing cost of the fuels, strict emissions rules to decrease the vehicle weight
Cognitive Assessment And Training In Healthcare Market Size, Share, Trends and C …
A detailed study of the competitive landscape of the cognitive assessment and training in healthcare market has been given here along with the insights of the companies, financial status, trending developments, mergers & acquisitions and SWOT analysis. This market report also provides comprehensive statistics on important aspects such as growth drivers, challenges and industry prospects. cognitive assessment and training in healthcare report includes a study on the marketing and development

All 5 Releases


More Releases for Treatment

Medical Tourism Market by Treatment Type (Dental Treatment, Cosmetic Treatment, …
Medical Tourism Market Overview: The global medical tourism market was valued at $53,768 million in 2017, and is estimated to reach at $143,461 million by 2025, registering a CAGR of 12.9% from 2018 to 2025. Organized travel across international borders to avail medical treatment of some form, which may or may not be available in the travelers home country is defined as medical tourism. Medical tourists travel abroad for the maintenance, enhancement,
Treatment of Patellofemoral Problems
The first line of treatment of patellofemoral problems focuses on reducing the inflammation in the knee. This can be achieved with rest and non-steroidal anti-inflammatory medication (NSAIDs) like Ibuprofen. Physical therapy may be advised for patients in the early stages of treatment. The therapy therapist may involves icing, massage, and/or ultrasound to prevent pain and swelling. Your surgeon or physical therapist may also recommend orthopedic bracing or taping for your
Anti-Snoring Treatment Market
Snoring is the vibration of respiratory structures which results in sound while sleeping. It is a sleeping disorder caused due to monotonous narrowing and collapsing of the upper airway. Snoring have various adverse effects on health include coronary artery disease, systemic hypertension, atrial fibrillation, and stroke. Snoring is one of the factors of sleep deprivation, which may be further caused due to throat weakness, mis-positioned jaw, obesity, and obstruction in
Acne Vulgaris Treatment Market
Acne vulgaris is a common skin disease characterized by blackheads, whiteheads, papules, and pustules on the face, neck, back, and chest. It is commonly observed in adolescent population, however, can also affect adults. Depending on its severity, acne may be segmented into mild, moderate or severe. It is caused due to excess oil produced in sebaceous glands under skin, which becomes plugged and inflated. Female patient with polycystic ovarian syndrome
Water Treatment Equipment Market
Water Treatment Equipment refers to the equipment used in the industrial water treatment. It includes Pre-treatment non-membrane, Pre-treatment membrane, ultrapure water, AD/EDI systems polishing, Inorganic WW treatment, Organic WW treatment, etc. The scope of the Report: This report focuses on the Water Treatment Equipment in the United States market, to split the market based on manufacturers, states, type and application. Sample Report Request: https://www.reportsandmarkets.com/sample-request/united-states-water-treatment-equipment-market-to-2022-1622845 Market Segment by Type, covers Pre-treatment non-membrane, Pre-treatment membrane, Ultrapure
Rheumatoid Arthritis Treatment Market
Rheumatoid arthritis (RA) is the most common autoimmune arthritis affecting more than 1.3 million U.S. citizens (American College of Rheumatology). More surprising is to know that around 75% of this affected population is women. Affecting the joints at any age, rheumatoid arthritis needs to be addressed early to avoid expensive joint replacement surgery. While it can affect any joint, small joints in hand and feet tend to be affected the